The impact of immunotherapies on COVID-19 case fatality rates during the US vaccination campaign: a multidisciplinary open data analysis using FDA Adverse Event Reporting System and Our World in Data

Introduction: Patients under immunotherapies were excluded from the pivotal trials of vaccinations against the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), and no population-level data on disease outcomes such as case fatality rates in relation to vaccination coverage exist. Ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Salmen, Anke, Marti, Stefanie, Hoepner, Andreas G. F., Chan, Andrew, Hoepner, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308012/
https://www.ncbi.nlm.nih.gov/pubmed/37397473
http://dx.doi.org/10.3389/fphar.2023.1186404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308012/
https://www.ncbi.nlm.nih.gov/pubmed/37397473
http://dx.doi.org/10.3389/fphar.2023.1186404

Ejemplares similares